Personalis Management

Management criteria checks 1/4

Personalis' CEO is Chris Hall, appointed in Dec 2022, has a tenure of 1.42 years. total yearly compensation is $1.73M, comprised of 30.9% salary and 69.1% bonuses, including company stock and options. directly owns 0.07% of the company’s shares, worth $56.91K. The average tenure of the management team and the board of directors is 2.8 years and 2 years respectively.

Key information

Chris Hall

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage30.9%
CEO tenure1.4yrs
CEO ownership0.07%
Management average tenure2.8yrs
Board average tenure2yrs

Recent management updates

Recent updates

Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Apr 19
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 02
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 31% Yet They're Still Not Telling The Full Story

Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Dec 18
Personalis, Inc.'s (NASDAQ:PSNL) Shares Leap 37% Yet They're Still Not Telling The Full Story

Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Dec 04
Will Personalis (NASDAQ:PSNL) Spend Its Cash Wisely?

Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Sep 04
Personalis (NASDAQ:PSNL) Will Have To Spend Its Cash Wisely

Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

Apr 17
Investors Holding Back On Personalis, Inc. (NASDAQ:PSNL)

The Prognosis For Personalis

Jun 16

Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Jun 09
Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Feb 17
Is Personalis (NASDAQ:PSNL) Using Debt In A Risky Way?

Personalis: Getting Personal Again

Feb 02

Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Nov 11
Health Check: How Prudently Does Personalis (NASDAQ:PSNL) Use Debt?

Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth

Oct 12
Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth

We're Hopeful That Personalis (NASDAQ:PSNL) Will Use Its Cash Wisely

Jul 05
We're Hopeful That Personalis (NASDAQ:PSNL) Will Use Its Cash Wisely

Personalis: Market-Leading Immuno-Oncology Platform Drives Consistent Long-Term Growth

Jun 21

CEO Compensation Analysis

How has Chris Hall's remuneration changed compared to Personalis's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$2mUS$534k

-US$108m

Sep 30 2023n/an/a

-US$113m

Jun 30 2023n/an/a

-US$110m

Mar 31 2023n/an/a

-US$114m

Dec 31 2022US$2mUS$83k

-US$113m

Compensation vs Market: Chris's total compensation ($USD1.73M) is above average for companies of similar size in the US market ($USD667.96K).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


CEO

Chris Hall (54 yo)

1.4yrs

Tenure

US$1,726,790

Compensation

Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Hall
President1.4yrsUS$1.73m0.070%
$ 56.9k
Aaron Tachibana
CFO & COO5.2yrsUS$1.67m0.29%
$ 233.1k
Stephen Moore
Senior VP4.1yrsUS$674.28k0.14%
$ 115.1k
Richard Chen
Executive VP of R&D and Chief Medical Officer2.8yrsUS$1.28m0.18%
$ 144.4k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Fitzpatrick
Vice President of Worldwide Sales11.1yrsno datano data
Christian Haudenschild
Senior Vice President of Genomic Laboratory Operations2.7yrsno datano data
Stephane Mouradian
Senior Vice President of Business Development1.3yrsno datano data
Deepshikha Bhandari
Senior Vice President of Regulatoryless than a yearno datano data

2.8yrs

Average Tenure

52yo

Average Age

Experienced Management: PSNL's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Hall
President1.2yrsUS$1.73m0.070%
$ 56.9k
Russ Altman
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Euan Ashley
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Michael Snyder
Co-Founder and Member of Clinical & Scientific Advisory Boardno datano datano data
Kenneth Widder
Independent Directorless than a yearUS$154.00kno data
Karin Eastham
Independent Chair of the Board4.7yrsUS$173.05k0.026%
$ 21.5k
Arthur Bowman
Independent Director5yrsUS$121.38k0.026%
$ 21.5k
Woodrow Myers
Independent Director3.2yrsUS$108.88k0.051%
$ 41.5k
John West
Advisor to the Board1.4yrsUS$5.62m0%
$ 0
Lonnie Shoff
Independent Director1.8yrsUS$103.88k0.020%
$ 16.4k
Olivia Bloom
Independent Director2.2yrsUS$116.38k0.034%
$ 28.0k

2.0yrs

Average Tenure

66yo

Average Age

Experienced Board: PSNL's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.